Buy IGF-1 LR3 — USA-Made, COA per Lot

Molecular Profile and Structural Modifications of IGF-1 LR3

Insulin-like Growth Factor 1 Long R3 (IGF-1 LR3) is a synthetic 83-amino-acid recombinant polypeptide analog of human IGF-1. The primary sequence contains two distinct structural modifications relative to native 70-amino-acid IGF-1: the substitution of an Arginine for Glutamic acid at position 3 (hence 'R3'), and a 13-amino-acid N-terminal extension peptide. These biochemical alterations were engineered specifically to address the rapid clearance rates associated with endogenous IGF-1 in cell culture media and animal models.

In native biological systems, endogenous IGF-1 binds tightly to circulating IGF Binding Proteins (IGFBPs, primarily IGFBP-3), which regulate its bioavailability and downregulate its interaction with the Type 1 IGF Receptor (IGF-1R). Preclinical studies demonstrate that the Arg3 substitution drastically reduces affinity for IGFBPs by over 100-fold. Concurrently, the 13-amino-acid extension maintains the binding capability to IGF-1R, allowing the peptide to remain biologically active in vitro for significantly extended periods. Researchers evaluating receptor binding kinetics and cell proliferation assays utilize the IGF-1 LR3 product to study sustained downstream signaling pathways without the confounding variable of competitive IGFBP sequestration.

Sourcing High-Purity IGF-1 LR3: Domestic vs. Overseas Manufacturing

When procurement departments and primary investigators decide to buy IGF-1 LR3, evaluating vendor sourcing standards is critical to experimental reproducibility. A substantial proportion of commercially available research peptides sourced from overseas manufacturers suffer from truncated peptide fragments, incomplete disulfide bond folding, residual trifluoroacetic acid (TFA) salts, and elevated bacterial endotoxin levels. Because IGF-1 LR3 is a complex 83-amino-acid tertiary structure containing three intramolecular disulfide bonds, sub-standard recombinant expression or chemical synthesis routinely produces misfolded, biologically inactive isoforms.

PX1 Research mitigates these experimental risks by maintaining strict domestic manufacturing standards. Our peptides are synthesized in state-of-the-art USA facilities operating under GMP-compliant guidelines. Domestic production allows for meticulous control over folding parameters, chromatographic purification, and lyophylization protocols. When research teams source from PX1, they avoid the variable batch quality, delayed custom clearances, and lack of lot traceability common among unverified overseas suppliers.

Analytical Rigor: Third-Party HPLC, MS, and Endotoxin Verification

To guarantee quantitative scientific reproducibility, every batch of IGF-1 LR3 offered by PX1 Research is subjected to independent, third-party laboratory verification at an ISO 17025 accredited facility. We do not rely on manufacturer self-attestation or static, recycled analytical reports. Each lot is assigned a unique tracking number linked directly to its lot-specific Certificate of Analysis (COA), accessible via our research portal.

Our comprehensive testing regimen encompasses three non-negotiable analytical metrics:

1. High-Performance Liquid Chromatography (HPLC): Confirms chemical purity exceeding 98%. HPLC chromatograms map chemical purity and detect potential deletion sequences or aggregation artifacts.

2. Electrospray Ionization Mass Spectrometry (ESI-MS): Verifies exact molecular mass (9,111 Da nominal) and confirms primary amino acid sequence fidelity.

3. Chromogenic LAL Endotoxin Testing: Measures lipopolysaccharide (LPS) contamination levels. High endotoxins induce inflammatory signaling cascades in cell cultures, skewing cellular viability and transcriptomic data. PX1 sets strict endotoxin limits (< 0.1 EU/mg) to preserve culture integrity.

Recombinant Expression and Disulfide Folding Fidelity

The molecular architecture of IGF-1 LR3 demands advanced expression and purification strategies. Unlike short linear peptides, the 83-amino-acid sequence requires exact tertiary folding to form three specific disulfide linkages: Cys6-Cys48, Cys18-Cys61, and Cys47-Cys52. Synthetic strategies utilizing improper refolding buffers yield scrambled disulfide isomers that display compromised receptor affinity and unpredictable bioactivity in target tissue assays.

PX1 Research utilizes optimized recombinant bacterial expression systems (E. coli) followed by multi-step high-resolution ion-exchange and reverse-phase HPLC purification. This process ensures correct disulfide pair formation and removes host cell proteins (HCP) and nucleic acid contaminants. Principal investigators conducting studies in structural biology, receptor pharmacology, or metabolic pathway signaling can rely on the structural integrity of our peptides for consistent baseline measurements.

Comparative Analysis: IGF-1 LR3 vs. Native IGF-1, IGF-1 DES, and MGF

In musculoskeletal, neurological, and endocrinological research, investigators frequently compare multiple growth factor analogs to evaluate target receptor selectivity and functional signaling duration. Understanding the operational differences between these molecules is essential when selecting compounds for specific experimental models.

When evaluating the IGF axis, investigators frequently compare IGF-1 DES, native IGF-1, and downstream splices like PEG-MGF. While native IGF-1 exhibits a short half-life due to rapid IGFBP binding, IGF-1 LR3 maintains prolonged stability in serum-containing media, making it ideal for multi-day cell culture protocols. Conversely, IGF-1 DES (1-3 IGF-1) lacks the N-terminal tripeptide, rendering it highly potent over a short clearance window—frequently applied in acute, localized receptor saturation experiments. In contrast, Mechano Growth Factor (MGF) operates via distinct splice-variant mechanisms involved in initial tissue injury response. Researchers studying broader growth factor pathways may also evaluate secretagogues such as CJC-1295 No DAC or BPC-157 within multi-variable tissue repair models.

In Vitro Research Applications and Signaling Mechanisms

In preclinical laboratory settings, IGF-1 LR3 is heavily utilized to investigate signal transduction cascades downstream of the Type 1 IGF Receptor (IGF-1R), a receptor tyrosine kinase. Ligand binding triggers receptor autophosphorylation, recruiting insulin receptor substrate (IRS) proteins and subsequently activating two primary pathways: the Phosphoinositide 3-kinase (PI3K)-AKT/mTOR pathway and the Mitogen-Activated Protein Kinase (MAPK/ERK) pathway.

Published in vitro data indicate that IGF-1 LR3 stimulation promotes:

- Myoblast Proliferation and Differentiation: Acceleration of satellite cell progression and upregulation of myogenin and MyoD transcripts in C2C12 cell lines.

- Protein Synthesis Modulation: Activation of p70S6 kinase and inhibition of glycogen synthase kinase-3 beta (GSK-3β), driving ribosomal biogenesis.

- Inhibition of Apoptotic Cascades: Suppression of caspase-3 activation and upregulation of Bcl-2 family anti-apoptotic proteins in primary chondrocyte and cardiomyocyte assays.

- Glucose and Amino Acid Transport: Potenciation of GLUT4 translocation in skeletal muscle and adipose cell culture models under insulin-free experimental parameters.

Handling, Reconstitution, and Storage Protocols for Laboratory Use

To maintain the structural stability of lyophilized IGF-1 LR3 and prevent aggregation or thermal degradation, standardized laboratory reconstitution protocols must be followed. Lyophilized cake should be stored at -20°C or -80°C upon receipt in a dry, dark environment.

For reconstitution, long-chain growth factors like IGF-1 LR3 exhibit hydrophobic regions that require specific solvent considerations:

1. Solubilization: Reconstitute using sterile 0.1M Acetic Acid or 10mM HCl to an initial concentration of 1.0 mg/mL. This acidic environment prevents peptide aggregation and ensures full dissolution.

2. Dilution: Once fully dissolved in dilute acid, the solution can be further diluted into physiological buffers such as Phosphate-Buffered Saline (PBS) containing 0.1% Bovine Serum Albumin (BSA) or Human Serum Albumin (HSA) as a carrier protein to prevent surface adsorption to plastic labware.

3. Aliquoting and Storage: Avoid repeated freeze-thaw cycles, which induce shear stress and polypeptide denaturing. Reconstituted stock solutions should be aliquoted into low-binding polypropylene microcentrifuge tubes and stored at -80°C for long-term experimental use.

Supply Chain Reliability, Same-Day Shipping, and Institutional Accounts

PX1 Research understands that academic and private research projects operate on strict timelines and grant schedules. Unexpected supply chain disruptions or delayed shipments can compromise long-term cell culture maintenance and animal study schedules. To support reliable laboratory operations, PX1 maintains robust inventory reserves across fulfillment hubs in California and Arizona.

Orders placed before 3:00 PM EST Monday through Friday are processed with same-day dispatch. All shipments are packed using temperature-stable insulated packaging to protect polypeptide structures from ambient thermal degradation during transit. University purchasing departments, contract research organizations (CROs), and institutional labs requiring volume orders or custom packaging can establish dedicated institutional accounts through our wholesale program to access volume tiering, master services agreements, and automated reorder schedules.